34th AGM voting results: all 5 resolutions passed with over 99.99 percent approval
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.9 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Genpharmasec Limited held its 34th AGM on September 29, 2026 via video conferencing. Five resolutions were passed with over 99.99 percent approval. These included adoption of audited standalone and consolidated financials for FY ending March 31, 2026, re-appointment of Mr. Sohan Chaturvedi as director retiring by rotation, his re-appointment as Whole-Time Director for 3 years, and approval for loans or guarantees under Section 185 of the Companies Act, 2013. Around 1,01,409 shareholders were on record. Poll turnout was about 37 percent for the first four resolutions and 69 percent for the Section 185 resolution.
Routine AGM business completed. WTD re-appointed for 3 years and board cleared to give loans or guarantees under Section 185.